Susceptibility to innate immune activation in genetically mediated myocarditis

Abstract

Conflict of Interest StatementEMM is a consultant for Amgen, Cytokinetics, PepGen, Tenaya Therapeutics, and is the founder of Ikaika Therapeutics. JO is currently an employee of AbbVie, and her contribution was prior to joining AbbVie. ALG receives research support from Biohaven Pharmaceutical, Praxis Precision Medicines, and Neurocrine Biosciences and has served as a consultant to Amgen. KJC haas consulted for Nuevocor. PWB has ownership interests in Clever Carnivore, and Defined Bioscience and receives royalty payments from Stanford University.